Perennial Real Estate Holdings Limited - Annual Report 2017

BGI Perennial Genomics Diagnostic Imaging Centre (“ BGI Perennial Genomics ”) is a 40-60 joint venture between Perennial and Hunan Xiangya Emergency Response Investment Management Co., Ltd 1 , with Perennial holding a 40% stake. Equipped with state-of-the-art diagnostic equipment and know- how, BGI Perennial Genomics offers a full suite of medical imaging services for health management and clinical diagnosis. The first upcoming facility will be located at PIHMH in Chengdu. Its primary specialties will be in health screening, medical imaging and tumour diagnosis. Focus Areas for FY2018 In FY2018, the focus will be on completing fitting-out works for the inaugural facility at PIHMH in Chengdu, which is expected to commence operations by 1H 2018. CT Scan Room Reception Area MRI Room 1 Hunan Xiangya Emergency Response Investment Management Co., Ltd ( ܯ ϓሲ ݔ ӷ ݡߤ ྽ΫѺϯȗĈՄȔѣ ) was nominated by BGI Management Holdings Co., Ltd ( Ͼę׼ȂֶԻϯȗ ܕߞ ĈՄȔѣ ) to enter into the joint venture with Perennial. Headquartered in Shenzhen, BGI Genomics is one of the world’s largest genomic sequencing organisations providing next generation sequencing services and a portfolio of genetic tests for medical and research institutions. Annual Report 2017 84 PERENNIAL REAL ESTATE HOLDINGS LIMITED BUSINESS REVIEW: HEALTHCARE – CHINA BGI PERENNIAL GENOMICS DIAGNOSTIC IMAGING CENTRE, CHENGDU юЁ ܘ Ͻឡᇴ۱ࣩѻؙՍᒎआЅК SUPPORTING SPECIALTIES

RkJQdWJsaXNoZXIy NTkwNzg=